Ondokuz Mayıs University

omu.edu.tr

Total trials

249

Active

61

Phase 3

0

Total enrollment

34,174

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 4 of 4 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
IV morphine patient-controlled analgesia2
Magnesium Sulfate1
0.9% Saline1
ibuprofen1

Next readouts

  • 2026-02-01
  • 2026-07-30
  • 2026-08-01

Top conditions

  • Anesthesia15
  • Anxiety12
  • Postoperative Pain10
  • Periodontitis9
  • Multiple Sclerosis8
  • Analgesia8
  • Acute Pain8
  • Periodontal Diseases6

Frequently asked questions about Ondokuz Mayıs University

How many clinical trials does Ondokuz Mayıs University have on ClinicalTrials.gov?
Ondokuz Mayıs University is listed as the lead sponsor on 249 clinical trials in ClinicalTrials.gov, 61 of which are currently active (recruiting, enrolling, or ongoing).
How many of Ondokuz Mayıs University's trials are in Phase 3?
0 of Ondokuz Mayıs University's trials are in Phase 3, spread across 4 active drug programs.
What therapeutic areas does Ondokuz Mayıs University focus on?
Ondokuz Mayıs University's most-studied conditions on ClinicalTrials.gov are Anesthesia, Anxiety, Postoperative Pain, Periodontitis, Multiple Sclerosis.
When are Ondokuz Mayıs University's next clinical trial readouts?
Ondokuz Mayıs University has 3 upcoming primary-completion readouts tracked here; the soonest is “Serratus Posterior Superior Plane Block for Postoperative Pain in Cardiac Surgery”, expected around 2026-02-01.